
Gulf Scientific Corporation announces strategic partnership with GeneMind Biosciences
DUBAI, United Arab Emirates: Gulf Scientific Corporation (GSC), a leading provider of scientific and laboratory solutions, is pleased to announce a strategic partnership with GeneMind Biosciences, a pioneering developer of DNA sequencing systems. This alliance marks a significant milestone in our ongoing commitment to delivering innovative healthcare solutions and advancing molecular diagnostics.
Founded with a focus on research and development, GeneMind Biosciences is a key player in the development of high-performance DNA sequencers - core instruments of modern molecular diagnostics. The company is committed to building a comprehensive precision medical ecosystem by collaborating with genetic testing service providers and medical institutions worldwide.
This partnership with GSC represents a shared vision to enhance diagnostic capabilities, support cutting-edge scientific research, and ultimately improve patient outcomes. By combining GSC's extensive network and expertise with GeneMind's innovative sequencing technology, we aim to drive forward the future of healthcare through advanced molecular diagnostics, including non-invasive prenatal testing (NIPT).
GSC is proud to represent GeneMind Biosciences in the UAE, Kuwait, Oman, Bahrain, and Qatar, bringing their groundbreaking NIPT technology to healthcare providers and patients across these markets.
GeneMind's cutting-edge NIPT technology allows for early and accurate detection of fetal chromosomal abnormalities, reducing the risk of miscarriage and improving pregnancy outcomes. This technology has the potential to revolutionize prenatal care and improve the lives of expectant mothers.
"We are excited to collaborate with GeneMind Biosciences, whose innovative DNA sequencing solutions align perfectly with our mission to empower healthcare providers to achieve their scientific objectives by providing innovative and reliable solutions, application support, and comprehensive after-sales services," stated Manaf Afyouni, Managing Director of Gulf Scientific Corporation. "Our partnership will enable us to bring cutting-edge NIPT technology to the region, enhancing prenatal care and improving patient outcomes."
As part of this strategic partnership, GSC will be providing comprehensive support and services to healthcare professionals within the region. This collaboration will also facilitate the development of new research initiatives and projects focused on advancing molecular diagnostics and NIPT.
We look forward to sharing updates on the groundbreaking initiatives and projects that will result from this strategic partnership.
For more information about Gulf Scientific Corporation and our solutions, including GeneMind's NIPT technology, please visit https://gulf-scientific.com/partners/genemind/
Source: AETOSWire
Contact details:
Manaf Afyouni
Email: marketing@gulf-scientific.com
Website: www.gulf-scientific.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
11 minutes ago
- Zawya
Dubai Chambers hosts Dubai-Uzbekistan Business Seminar
H.E. Mohammad Ali Rashed Lootah: ' Today's seminar creates a valuable opportunity to further build upon the impressive growth in trade between Dubai and Uzbekistan. ' Non-oil trade between Dubai and Uzbekistan achieved annual growth of 66% during 2024 to exceed AED 11.1 billion. The meeting focused on strengthening collaboration, supporting business expansion, and increasing bilateral trade and investments. Dubai, UAE – Dubai Chambers welcomed a high-level delegation from Uzbekistan today led by H.E. Laziz Kudratov, Minister of Investment, Industry, and Trade of the Republic of Uzbekistan, to participate in the Dubai-Uzbekistan Business Seminar. The event, attended by around 100 businessmen, served as a platform to strengthen economic cooperation and explore opportunities to increase bilateral trade and investments. The seminar was attended by senior government officials from Uzbekistan, together with deputy ministers and governors of key Uzbek regions and prominent figures from the Dubai and Uzbekistan business communities. His Excellency Mohammad Ali Rashed Lootah, President and CEO of Dubai Chambers, commented: 'Today's seminar creates a valuable opportunity to further build upon the impressive growth in trade between Dubai and Uzbekistan. We are eager to explore new paths for collaboration and investment to drive mutual economic growth. Dubai Chambers remains committed to supporting Uzbek companies in leveraging Dubai's world-class infrastructure and strategic location to accelerate their international expansion.' His Excellency emphasised Dubai Chambers' dedication to supporting the success of the Uzbek business community in Dubai and assisting Uzbek companies in harnessing the emirate's competitive advantages as a hub for connecting with global opportunities. The seminar included presentations on the business and investment landscapes in both Dubai and Uzbekistan, exploring mutually beneficial synergies and promising opportunities in both markets. Discussions also focused on increasing bilateral trade and investments between the two markets. The value of non-oil trade between Dubai and Uzbekistan achieved annual growth of 66% during 2024 to exceed AED 11.1 billion. Key Uzbek exports to Dubai include precious stones and metals, zinc, fruit and nuts, and copper, while Dubai's main exports to Uzbekistan include electronics, machinery, vehicles, precious stones and metals, and perfumes and cosmetics. During the event, the two sides discussed opportunities to boost trade exchange in line with the strengths and areas of high potential in both economies. The sessions during the event also highlighted the strong and growing presence of Uzbek companies in Dubai. By the end of 2024, over 700 Uzbek companies were registered as active members of the Dubai Chamber of Commerce, marking a robust year-over-year growth rate of 34.5%. This upward trajectory has continued into 2025, with over 60 new Uzbek companies joining the chamber during the first quarter alone, bringing fresh momentum to bilateral business ties. About Dubai Chambers Dubai Chambers is a non-profit public entity that supports Dubai's vision as a global player by empowering businesses, delivering innovative value-added services, and unlocking access to influential networks. In March 2021, His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, announced the restructuring of Dubai Chamber of Commerce and the formation of three chambers for the emirate, namely Dubai Chamber of Commerce, Dubai International Chamber, and Dubai Chamber of Digital Economy, which now operate under the umbrella of Dubai Chambers. Follow us on: For more information, please contact: Mohamad Mouzehem PR & Corporate Communications Email:


Zawya
11 minutes ago
- Zawya
DoH – Abu Dhabi and Sanofi forge strategic alliance to accelerate the development of new global vaccines in Abu Dhabi
Abu Dhabi, United Arab Emirates: The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of Understanding (MoU) with Sanofi, a research and development-driven, AI-powered healthcare biopharma company at the BIO International Convention 2025, in Boston, USA. The collaboration will leverage the Emirate's health-tech ecosystem and advanced research infrastructure to drive the development of new global vaccines and strengthen regional capabilities in vaccine manufacturing. In the presence of H.E. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi and Laurie Gery. Global Head of Business Development, Vaccines at Sanofi, the agreement was signed during the BIO International Convention in Boston, USA, by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Baptiste de Clarens, General Manager Greater Gulf, Vaccines at Sanofi. Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH, said: 'DoH is partnering with Sanofi to expedite the development of new global vaccines. This initiative aims to shorten the timeline from early research to public availability by utilising advanced technologies, real-time data analysis, and conducting parallel clinical trial phases. By combining Sanofi's global scientific expertise with Abu Dhabi's state-of-the-art infrastructure, we set new benchmarks for resilience, innovation and international partnerships. Abu Dhabi offers a globally connected, purpose-driven environment for leading research and together we will drive a transformative change that will safeguard the health and well-being of our community while contributing to global health security.' Both entities will work together to streamline regulatory processes, enhance manufacturing preparedness, and promote knowledge sharing between local and international experts. This partnership reflects Abu Dhabi's strategic goal to establish itself as a leading center for bio- and pharmaceutical innovation and underscores the emirate's commitment to advancing proactive, technology-driven healthcare solutions. Baptiste de Clarens, General Manager Greater Gulf, Vaccines, Sanofi, said: 'The Memorandum of Understanding signed with the Department of Health – Abu Dhabi marks an encouraging step towards advancing global health security while reflecting our shared interest in addressing global health challenges through scientific partnership. This agreement allows us to examine how Sanofi's experience in vaccine development could complement Abu Dhabi's growing R&D ecosystem. Through this initial framework, we look forward to exploring opportunities for public-private collaboration in healthcare innovation.' In addition, both the Department and Sanofi will advance clinical research and development planning, optimise resource allocation and establish the foundational terms for funding and access. These efforts are designed to enhance healthcare resilience and sustainability across Abu Dhabi's healthcare sector and beyond, expanding access to quality care for patients locally and globally. Led by DoH, a high-level delegation has embarked on a strategic mission to the United States from June 15 to 21, delegation will conduct over 20 strategic meetings and visits with public and private sector leaders across the U.S., aimed at knowledge exchange, investment opportunities and the signing of new agreements that accelerate the adoption of advanced health solutions. Representing Abu Dhabi's innovation ecosystem, the delegation includes key stakeholders such as the Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD, PureHealth, and Etihad Cargo, New York University Abu Dhabi (NYUAD), Khalifa University, startAD and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI). About the Department of Health – Abu Dhabi (DoH): The Department of Health – Abu Dhabi is the regulative body of the healthcare sector in the Emirate of Abu Dhabi. Committed to ensuring excellence in healthcare, DoH monitors the health status of the population while shaping the regulatory framework for the health system. This includes inspecting against regulations, enforcing standards and encouraging the adoption of world-class best practices and performance targets by all healthcare providers in the Emirate. Abu Dhabi remains dedicated to shaping the future of healthcare by establishing an intelligent and sustainable ecosystem that prioritises health, longevity and quality of life for all community members. Leveraging state-of-the-art infrastructure and cutting-edge capabilities, DoH continues to develop and implement initiatives and programmes in line with its strategic focus areas, Healthy Population, Best-in-Class Care and Resilience and Innovation. These efforts reflect DoH's unwavering commitment to predicting, preventing and personalising healthcare for every individual. For further information on DOH, visit and follow on X, Instagram, Facebook, LinkedIn and YouTube. For media inquiries, please contact: Mariam Al Marzooqi, msalmarzooqi@


Zawya
11 minutes ago
- Zawya
Abu Dhabi Civil Defense Authority receives the 2025 NFPA Fire & Life Safety Ecosystem Global Influencer Award
United Arab Emirates – The National Fire Protection Association® (NFPA®) has announced that the Abu Dhabi Civil Defense Authority (ADCDA) has been selected as the recipient of the 2025 NFPA Fire & Life Safety Ecosystem Global Influencer Award. The award was presented at the NFPA Stars at Night awards gala on Sunday, June 15, during the annual NFPA Conference & Expo in Las Vegas. Established in 2024, the NFPA Fire & Life Safety Ecosystem Global Influencer Award recognizes individuals or organizations who advance safety by applying and promoting the principles of the NFPA Fire & Life Safety Ecosystem™. ' We are deeply honored to receive the 2025 NFPA Fire & Life Safety Ecosystem Global Influencer Award. Our strategic collaboration with NFPA has been vital in elevating our workforce capabilities and fostering a holistic safety ecosystem across the emirate of Abu Dhabi. As we continue to lead with innovation and resilience, we reaffirm our dedication to safeguarding our communities and positioning the UAE as a global benchmark for excellence in safety and emergency response, ' said, H.E. Brigadier General Salem Abdulla Al Dhaheri, Director General, Abu Dhabi Civil Defense Authority. ' Abu Dhabi Civil Defense Authority has a forward-thinking leadership that is building a strategy around all elements of the Fire & Life Safety Ecosystem to achieve real-world results, ' said NFPA President and CEO Jim Pauley. ' Their commitment to innovation, training, and outreach has contributed to measurable gains in public safety, including a reported 64 percent reduction in fire deaths per 100,000 people since 2021. ' The ADCDA was selected for its comprehensive and sustained commitment to safety innovation, risk reduction, and capacity building across the United Arab Emirates. Of particular note is the authority's three-year certification program, developed in collaboration with NFPA, to provide advanced training for engineers, inspectors, and hazardous materials specialists. This initiative exemplifies ADCDA's investment in workforce development and operational excellence. NFPA's Fire & Life Safety Ecosystem™ emphasizes eight key components that must work together to protect people and property. ADCDA has taken a system-wide approach to address policy, enforcement, investment, education, and emergency response, serving as a model of safety leadership in the Middle East and globally. For more information about the Stars at Night awards, visit the NFPA Awards webpage. For this release and other announcements about NFPA initiatives, research, and resources, please visit the NFPA press room. About the National Fire Protection Association ® (NFPA ®) Founded in 1896, NFPA® is a global self-funded nonprofit organization devoted to eliminating death, injury, property, and economic loss due to fire, electrical, and related hazards. The association delivers information and knowledge through more than 300 consensus codes and standards, research, training, education, outreach, and advocacy; and by partnering with others who share an interest in furthering the NFPA mission. For more information, visit All NFPA codes and standards can be viewed online for free at Contact: Ronak Thakkar – Associate Director - FleishmanHillard Mail: